Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/140273
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBroman, K.K.-
dc.contributor.authorHughes, T.-
dc.contributor.authorDossett, L.-
dc.contributor.authorSun, J.-
dc.contributor.authorKirichenko, D.-
dc.contributor.authorCarr, M.J.-
dc.contributor.authorSharma, A.-
dc.contributor.authorBartlett, E.K.-
dc.contributor.authorNijhuis, A.A.G.-
dc.contributor.authorThompson, J.F.-
dc.contributor.authorHieken, T.J.-
dc.contributor.authorKottschade, L.-
dc.contributor.authorDowns, J.-
dc.contributor.authorGyorki, D.E.-
dc.contributor.authorStahlie, E.-
dc.contributor.authorvan Akkooi, A.-
dc.contributor.authorOllila, D.W.-
dc.contributor.authorFrank, J.-
dc.contributor.authorSong, Y.-
dc.contributor.authorKarakousis, G.-
dc.contributor.authoret al.-
dc.date.issued2021-
dc.identifier.citationCancer, 2021; 127(13):2251-2261-
dc.identifier.issn0008-543X-
dc.identifier.issn1097-0142-
dc.identifier.urihttps://hdl.handle.net/2440/140273-
dc.descriptionPublished online April 7, 2021-
dc.description.abstractAbstract not available-
dc.description.statementofresponsibilityKristy Kummerow Broman ... Hidde M. Kroon ... et al.-
dc.language.isoen-
dc.publisherWiley-
dc.rights© 2021 American Cancer Society.-
dc.source.urihttp://dx.doi.org/10.1002/cncr.33483-
dc.subjectactive surveillance-
dc.subjectcohort studies-
dc.subjectcutaneous malignant melanoma-
dc.subjectfollow-up studies-
dc.subjectimmunotherapy-
dc.subjectlymph node excision-
dc.subjectmetastatic melanoma-
dc.subjectsentinel lymph node-
dc.subject.meshHumans-
dc.subject.meshMelanoma-
dc.subject.meshSkin Neoplasms-
dc.subject.meshNeoplasm Recurrence, Local-
dc.subject.meshSentinel Lymph Node Biopsy-
dc.subject.meshLymph Node Excision-
dc.subject.meshRetrospective Studies-
dc.subject.meshAdult-
dc.subject.meshWatchful Waiting-
dc.subject.meshSentinel Lymph Node-
dc.titleActive surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy trial II (MSLT-2)-
dc.typeJournal article-
dc.identifier.doi10.1002/cncr.33483-
pubs.publication-statusPublished-
dc.identifier.orcidKroon, H.M. [0000-0002-8923-7527]-
Appears in Collections:Surgery publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.